<p>WIN prevents the increase of IL-1β and TNF-α secretion caused by Aβ<sub>1–42</sub> in astrocytes. Cells were incubated with 10 μM Aβ<sub>40–1</sub> (control peptide, C), 10 μM Aβ<sub>1–42</sub> (Aβ), 10 μM WIN + 10 μM control peptide (WIN) and 10 μM WIN + 10 μM Aβ<sub>1–42</sub> (WIN + Aβ). Cell culture supernatants were harvested, and IL-1β (panel A) and TNF-α (panel B) secretion were determined by ELISA. Values are means ± SD of replicate experiments from 4 independent astrocytes cultures. *<i>p</i><0.05 <i>vs</i> control astrocytes. #<i>p</i><0.05 <i>vs</i> Aβ<sub>1–42</sub> treated cells.</p
<p>Human NPCs were pre-treated with neutralizing antibody for LIF and were then treated with TNF-α f...
Before antibiotics and vaccines were discovered, microbes were the primary cause of mortality rates....
<p>A) SK-N-MC cells were stimulated during the indicated time with TNF-α (20 ng/ml). Cell lysates we...
<p>Astrocytes (panel A) or neurons (panel B) were incubated without Rn (control, C) or with Rn (10<s...
<p>(A) <i>Cxcl2</i>, <i>Ccl2</i>, and <i>Ccl20</i> mRNA levels in astrocytes, determined by qPCR. As...
<p>(A) Astrocytes viability induced by WIN. Concentration-dependent viability of WIN (1, 2, 5, 10 μM...
<p>(A) <i>Shh</i> mRNA levels in astrocytes, determined by qPCR. Astrocytes were treated with IL-1β ...
<p>Induction of IP-10 and intracellular localisation following treatment with IL-1β or TNFα reveals ...
<p>A) BV2 cells were treated with TFM-C (50µM) for 2h and stimulated with LPS (1µg/ml) for 3, 6 and ...
<p>Untreated or LPS primed microglia were stimulated with amyloid-β (Aβ)<sub><b>25–35</b></sub> (20 ...
<p>Three patient-derived glioma cell lines (one low grade astrocytoma and two GBM cells) were tested...
<p>NT2-astrocytes were stimulated with a range of concentrations of IL-1β and TNFα (50 ng/mL to 5pg/...
<p>Human astrocytes or HEK293 cells were transfected with IL-1β/GFP or GFP expression plasmids as de...
<p>The production of IL-1β protein (intracellular A and secreted B) was examined in U251, U87, human...
<div><p>Background</p><p>Astrocytes have critical roles in the human CNS in health and disease. They...
<p>Human NPCs were pre-treated with neutralizing antibody for LIF and were then treated with TNF-α f...
Before antibiotics and vaccines were discovered, microbes were the primary cause of mortality rates....
<p>A) SK-N-MC cells were stimulated during the indicated time with TNF-α (20 ng/ml). Cell lysates we...
<p>Astrocytes (panel A) or neurons (panel B) were incubated without Rn (control, C) or with Rn (10<s...
<p>(A) <i>Cxcl2</i>, <i>Ccl2</i>, and <i>Ccl20</i> mRNA levels in astrocytes, determined by qPCR. As...
<p>(A) Astrocytes viability induced by WIN. Concentration-dependent viability of WIN (1, 2, 5, 10 μM...
<p>(A) <i>Shh</i> mRNA levels in astrocytes, determined by qPCR. Astrocytes were treated with IL-1β ...
<p>Induction of IP-10 and intracellular localisation following treatment with IL-1β or TNFα reveals ...
<p>A) BV2 cells were treated with TFM-C (50µM) for 2h and stimulated with LPS (1µg/ml) for 3, 6 and ...
<p>Untreated or LPS primed microglia were stimulated with amyloid-β (Aβ)<sub><b>25–35</b></sub> (20 ...
<p>Three patient-derived glioma cell lines (one low grade astrocytoma and two GBM cells) were tested...
<p>NT2-astrocytes were stimulated with a range of concentrations of IL-1β and TNFα (50 ng/mL to 5pg/...
<p>Human astrocytes or HEK293 cells were transfected with IL-1β/GFP or GFP expression plasmids as de...
<p>The production of IL-1β protein (intracellular A and secreted B) was examined in U251, U87, human...
<div><p>Background</p><p>Astrocytes have critical roles in the human CNS in health and disease. They...
<p>Human NPCs were pre-treated with neutralizing antibody for LIF and were then treated with TNF-α f...
Before antibiotics and vaccines were discovered, microbes were the primary cause of mortality rates....
<p>A) SK-N-MC cells were stimulated during the indicated time with TNF-α (20 ng/ml). Cell lysates we...